Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Income from Continuing Operations (2016 - 2025)

Mimedx's Income from Continuing Operations history spans 15 years, with the latest figure at 15189000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 104.21% year-over-year to 15189000.0; the TTM value through Dec 2025 reached 48578000.0, up 15.67%, while the annual FY2025 figure was 48578000.0, 15.67% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 15189000.0 at Mimedx, down from 16748000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 51288000.0 in Q4 2023 and bottomed at 10868000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 7230500.0 (2024), against an average of 5885450.0.
  • The largest YoY upside for Income from Continuing Operations was 4864.65% in 2022 against a maximum downside of 510.91% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 198000.0 in 2021, then surged by 4864.65% to 9830000.0 in 2022, then soared by 421.75% to 51288000.0 in 2023, then plummeted by 85.5% to 7438000.0 in 2024, then skyrocketed by 104.21% to 15189000.0 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Income from Continuing Operations are 15189000.0 (Q4 2025), 16748000.0 (Q3 2025), and 9618000.0 (Q2 2025).